Yasuhide Miyoshi

13PUBLICATIONS
12CO-AUTHORS
Bioinformatic methods developmentInstruments and techniquesPredictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 23, 2025
Prognostic Value of BONENAVI Computer-Aided Diagnosis System Bone Scans as an Imaging Biomarker for Bone-Metastatic Castration-Sensitive Prostate Cancer: An Investigator-Initiated, Multicenter, Prospective Observational Study.

Yasuhide Miyoshi, Hiroji Uemura, Junichi Ohta

|Aug 17, 2022
Administration of radium-223 and the prognosis in Japanese bone metastatic castration-resistant prostate cancer patients: A large database study.

Takashi Kawahara, Yasuhide Miyoshi, Sahoko Ninomiya

|Apr 27, 2022
A novel prognostic model for Japanese patients with newly diagnosed bone-metastatic hormone-naïve prostate cancer.

Yasuhide Miyoshi, Masato Yasui, Shuko Yoneyama

|Apr 27, 2022
Prognostic value of automated bone scan index for predicting overall survival among bone metastatic castration resistant prostate cancer patients treated with radium-223.

Yasuhide Miyoshi, Sohgo Tsutsumi, Takashi Kawahara

|Apr 27, 2022
A lower psoas muscle index predicts a poorer prognosis in metastatic hormone-naïve prostate cancer.

Genta Iwamoto, Takashi Kawahara, Toshitaka Miyai

|Apr 27, 2022
Prognosis and safety of radium-223 with concurrent abiraterone acetate or enzalutamide use for metastatic castration-resistant prostate cancer: Real-world data of Japanese patients.

Yasuhide Miyoshi, Masato Yasui, Sohgo Ttsutsumi

Pageof 3

Frequent Collaborators

8 joint publications

Takashi Kawahara

4 joint publications

Masato Yasui

3 joint publications

Hiroji Uemura

2 joint publications

Naruhiko Hayashi